FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Edith Fressinaud

Research Profile

Disorders

Chemicals & Drugs

Physiology

Anatomy

Procedures

DNA Mutational Analysis

Concepts & Ideas

Living Beings

Heterozygote

Co-author Network

Publications

TOP 3
Paulette Legendre; Peter J Lenting; Ana-Maria Navarrete; Julie Rayes; Catherine Ternisien; Agnès Veyradier; Pierre Boisseau; Claudine Caron; Caterina Casari; Cécile V Denis; Edith Fressinaud; Jenny Goudemand; Olivier D Christophe
Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein.
Agnès Veyradier; M Wolf; C Caron; Edith Fressinaud; Catherine Ternisien; Marc Trossaert; J Goudemand
Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
Pierre Boisseau; Stéphane Bezieau; Edith Fressinaud; Mathilde Giraud; Armelle Lefrancois; Catherine Ternisien; Agnès Veyradier; Marc Fouassier
An unexpected transmission of von Willebrand disease type 3: the first case of maternal uniparental disomy 12.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Edith Fressinaud (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Paulette Legendre; Peter J Lenting; Ana-Maria Navarrete; Julie Rayes; Catherine Ternisien; Agnès Veyradier; Pierre Boisseau; Claudine Caron; Caterina Casari; Cécile V Denis; Edith Fressinaud; Jenny Goudemand; Olivier D Christophe
Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein.
Blood 2013;121(11):2135-43.
2011: Agnès Veyradier; M Wolf; C Caron; Edith Fressinaud; Catherine Ternisien; Marc Trossaert; J Goudemand
Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(6):944-51.
2011: Pierre Boisseau; Stéphane Bezieau; Edith Fressinaud; Mathilde Giraud; Armelle Lefrancois; Catherine Ternisien; Agnès Veyradier; Marc Fouassier
An unexpected transmission of von Willebrand disease type 3: the first case of maternal uniparental disomy 12.
Haematologica 2011;96(10):1567-8.
2009: J C J Eikenboom; L Hilbert; A S Ribba; A Hommais; David Habart; S Messenger; A Al-Buhairan; A Guilliatt; W Lester; Claudine Mazurier; Dominique Meyer; Edith Fressinaud; Ulrich Budde; K Will; Reinhard Schneppenheim; T Obser; O Marggraf; E Eckert; Giancarlo Castaman; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Jenny Goudemand; Jørgen Ingerslev; Stefan Lethagen; Frank Hill; Ian R Peake; Anne C Goodeve
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1304-12.
2008: Giancarlo Castaman; Stefan Lethagen; Augusto B Federici; Alberto Tosetto; Anne Goodeve; Ulrich Budde; Javier Batlle; Dominique Meyer; Claudine Mazurier; Edith Fressinaud; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; John Pasi; Frank Hill; Ian Peake; Francesco Rodeghiero
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
Blood 2008;111(7):3531-9.
2008: Marc Trossaërt; V Regnault; Marianne Sigaud; P Boisseau; Edith Fressinaud; T Lecompte
Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype.
Journal of thrombosis and haemostasis : JTH 2008;6(3):486-93.
2007: Mohammad Hashemi Soteh; Ian R Peake; Luke Marsden; John Anson; Javier Batlle; Dominique Meyer; Edith Fressinaud; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Anne C Goodeve
Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques.
Haematologica 2007;92(4):550-3.
2007: Agnès Veyradier; Marc Trossaert; A Lefrancois; Edith Fressinaud; Dominique Meyer
von Willebrand factor collagen binding assay with a commercial kit using type III collagen in von Willebrand disease type 2.
Journal of thrombosis and haemostasis : JTH 2007;5(4):868-70.
2007: Carina J M van Schooten; Cécile V Denis; Ton Lisman; J C J Eikenboom; Frank W G Leebeek; Jenny Goudemand; Edith Fressinaud; H Marijke van den Berg; Philip G de Groot; Peter J Lenting
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels.
Blood 2007;109(6):2430-7.
2007: Marc Dauty; Marianne Sigaud; Marc Trossaërt; Edith Fressinaud; Joseph Letenneur; Charles Dubois
Iliopsoas hematoma in patients with hemophilia: a single-center study.
Joint, bone, spine : revue du rhumatisme 2007;74(2):179-83.
2006: Paquita Nurden; Najet Debili; William Vainchenker; Regis BOBE; Raymonde Bredoux; Elisabeth Corvazier; Robert Combrie; Edith Fressinaud; Dominique Meyer; Alan T Nurden; Jocelyne Enouf
Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.
Blood 2006;108(8):2587-95.
2006: Sebastien Schmitt; Marc Trossaert; Fabrice Airaud; Gaelle Landeau-Trottier; Patricia Talarmain; Pierre Boisseau; Edith Fressinaud; Stephane Bezieau
Molecular misdiagnosis in type 2B von Willebrand disease.
American journal of hematology 2006;81(10):805-6.
2006: Lysiane Hilbert; Paquita Nurden; Claudine Caron; Alan T Nurden; Jenny Goudemand; Dominique Meyer; Edith Fressinaud; Claudine Mazurier
Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
Thrombosis and haemostasis 2006;96(3):290-4.
2006: Antoine Hommais; Alain Stépanian; Edith Fressinaud; Claudine Mazurier; Katia Pouymayou; Dominique Meyer; Jean-Pierre Girma; Anne-Sophie Ribba
Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.
Thrombosis and haemostasis 2006;95(5):776-81.
2006: Alberto Tosetto; Francesco Rodeghiero; Giancarlo Castaman; Anne C Goodeve; Augusto B Federici; Javier Batlle; Dominique Meyer; Edith Fressinaud; Claudine Mazurier; Jenny Goudemand; J C J Eikenboom; Reinhard Schneppenheim; Ulrich Budde; Jørgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank Hill; Ian R Peake
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
Journal of thrombosis and haemostasis : JTH 2006;4(4):766-73.
2006: Antoine Hommais; A Stépanian; Edith Fressinaud; Claudine Mazurier; Dominique Meyer; Jean-Pierre Girma; Anne-Sophie Ribba
Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion.
Journal of thrombosis and haemostasis : JTH 2006;4(1):148-57.
2005: Edith Fressinaud; Dominique Meyer
[Von Willebrand disease: from diagnosis to treatment].
La Revue du praticien 2005;55(20):2209-18.
2005: Natalie Stieltjes; Thierry Calvez; V Demiguel; MF Torchet; Marie-Elisabeth Briquel; Edith Fressinaud; Ségolène Claeyssens; B Coatmelec; Hervé Chambost
Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(5):452-8.
2004: Lysiane Hilbert; Roseline d'Oiron; Edith Fressinaud; D Meyer; Claudine Mazurier
First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene.
Journal of thrombosis and haemostasis : JTH 2004;2(12):2271-3.
2004: Odile Herbert; Marc Trossaërt; P Boisseau; Edith Fressinaud; F Gerson
Evaluation of denaturing high-performance liquid chromatography (DHPLC) in the screening of mutations in hemophilia B patients.
Journal of thrombosis and haemostasis : JTH 2004;2(12):2267-9.
2004: Lysiane Hilbert; Sylvie Jorieux; M Fontenay-Roupie; M Guicheteau; Edith Fressinaud; Dominique Meyer; Claudine Mazurier
Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene.
British journal of haematology 2004;127(2):184-9.
2004: F Quélin; Marc Trossaërt; Marianne Sigaud; P D E Mazancourt; Edith Fressinaud
Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation.
Journal of thrombosis and haemostasis : JTH 2004;2(1):71-6.
2003: Benoit Piot; Marianne Sigaud-Fiks; P Huet; Edith Fressinaud; Marc Trossaërt; Jacques Mercier
[Dental extraction in patients with bleeding disorders. Proposal of a protocol based on the type of anesthesia used].
Revue de stomatologie et de chirurgie maxillo-faciale 2003;104(2):73-6.
2003: Alain Stepanian; Anne-Sophie Ribba; Jean-Maurice Lavergne; Edith Fressinaud; Irène Juhan-Vague; Claudine Mazurier; Jean-Pierre Girma; Dominique Meyer
A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
British journal of haematology 2003;120(4):643-51.
2003: Lysiane Hilbert; Sylvie Jorieux; VALERIE PROULLE; Rémi Favier; Jenny Goudemand; Armelle Parquet; Dominique Meyer; Edith Fressinaud; Claudine Mazurier
Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity.
British journal of haematology 2003;120(4):627-32.
2002: Isabelle Martin; Fayçal Kriaa; VALERIE PROULLE; Benoît Guillet; Cécile Kaplan; Roseline d'Oiron; Marianne Debré; Edith Fressinaud; Yves Laurian; Gil Tchernia; Bernard Charpentier; Thierry Lambert; Marie Dreyfus
Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
British journal of haematology 2002;119(4):991-7.
2002: Lysiane Hilbert; Edith Fressinaud; Anne-Sophie Ribba; D Meyer; Claudine Mazurier
Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
Thrombosis and haemostasis 2002;87(4):635-40.
2002: Benoit Piot; Marianne Sigaud-Fiks; Pascal Huet; Edith Fressinaud; Marc Trossaërt; Jacques Mercier
Management of dental extractions in patients with bleeding disorders.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2002;93(3):247-50.
2002: Edith Fressinaud; Claudine Mazurier; Dominique Meyer
Molecular genetics of type 2 von Willebrand disease.
International journal of hematology 2002;75(1):9-18.
2001: C Ruiz; C Y Liu; Qi-Hong Sun; Marianne Sigaud-Fiks; Edith Fressinaud; Jean-Yves Muller; P Nurden; A T Nurden; Peter J Newman; Nathalie Valentin
A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
Blood 2001;98(8):2432-41.
2001: D Meyer; Edith Fressinaud; Lysiane Hilbert; Anne-Sophie Ribba; Jean-Maurice Lavergne; Claudine Mazurier
Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.
Best practice & research. Clinical haematology 2001;14(2):349-64.
2001: Claudine Mazurier; Jenny Goudemand; Lysiane Hilbert; Claudine Caron; Edith Fressinaud; D Meyer
Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology.
Best practice & research. Clinical haematology 2001;14(2):337-47.
2001: A N Ribba; Lysiane Hilbert; Jean-Maurice Lavergne; Edith Fressinaud; C Boyer-Neumann; C Ternisien; Irène Juhan-Vague; Jenny Goudemand; Jean-Pierre Girma; Claudine Mazurier; Dominique Meyer
The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor.
Blood 2001;97(4):952-9.
2000: Agnès Veyradier; Edith Fressinaud; C Boyer-Neumann; Marc Trossaert; Dominique Meyer
von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system.
Thrombosis and haemostasis 2000;84(4):727-8.
2000: J M Costa; Dominique Vidaud; Ingrid Laurendeau; M Vidaud; Edith Fressinaud; J P Moisan; A David; D Meyer; J M Lavergne
Somatic mosaicism and compound heterozygosity in female hemophilia B.
Blood 2000;96(4):1585-7.
2000: Agnès Veyradier; C S Jenkins; Edith Fressinaud; D Meyer
Acquired von Willebrand syndrome: from pathophysiology to management.
Thrombosis and haemostasis 2000;84(2):175-82.
2000: Sylvie Jorieux; Edith Fressinaud; Jenny Goudemand; Christine Gaucher; Dominique Meyer; Claudine Mazurier
Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment.
Blood 2000;95(10):3139-45.
2000: Roseline d'Oiron; C Ménart; Marie C Trzeciak; Paquita Nurden; Edith Fressinaud; Marie Dreyfus; Yves Laurian; Claude Négrier
Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures.
Thrombosis and haemostasis 2000;83(5):644-7.
2000: H Tout; Bernadette Obert; Anne Houllier; Edith Fressinaud; Chantal Rothschild; Dominique Meyer; Jean-Pierre Girma
Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
Thrombosis and haemostasis 2000;83(2):274-81.
1999: Bernadette Obert; H Tout; Agnès Veyradier; Edith Fressinaud; Dominique Meyer; Jean-Pierre Girma
Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.
Thrombosis and haemostasis 1999;82(5):1382-5.
1999: Edith Fressinaud; Agnès Veyradier; Marianne Sigaud; C Boyer-Neumann; C Le Boterff; Dominique Meyer
Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates.
British journal of haematology 1999;106(3):777-83.
1999: Agnès Veyradier; Edith Fressinaud; Marianne Sigaud; M Wolf; Dominique Meyer
[Evaluation of a new automated method for von Willebrand factor antigen measurement: the STA-Liatest vWF].
Annales de biologie clinique 1999;57(3):364-8.
1999: Agnès Veyradier; Edith Fressinaud; Marianne Sigaud; M Wolf; Dominique Meyer
A new automated method for von Willebrand factor antigen measurement using latex particles.
Thrombosis and haemostasis 1999;81(2):320-1.
1998: Chantal Rothschild; Yves Laurian; E P Satre; Annie Borel-Derlon; Hervé Chambost; P Moreau; Jenny Goudemand; Armelle Parquet; Jocelyne Peynet; M Vicariot; P Beurrier; Ségolène Claeyssens; Anne Durin; Albert Faradji; Edith Fressinaud; S Gaillard; V Guérin; C Guérois; Gilles Pernod; P Pouzol; Jean-François Schved; C Gazengel
French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance.
Thrombosis and haemostasis 1998;80(5):779-83.
1998: Marc Trossaërt; A Gaillard; P L Commin; Jean Amiral; Anne Marie Vissac; Edith Fressinaud
High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery.
British journal of haematology 1998;101(4):653-5.
1998: Jean-Pierre Girma; Edith Fressinaud; Anne Houllier; Yves Laurian; Jean Amiral; Dominique Meyer
Assay of factor VIII antigen (VIII:CAg) in 294 haemophilia A patients by a new commercial ELISA using monoclonal antibodies.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(2):98-103.
1998: Florence Kyndt; Jean-Jacques Schott; Jean-Noël Trochu; F Baranger; Odile Herbert; V Scott; Edith Fressinaud; A David; Jean-Paul Moisan; Jean-Brieuc Bouhour; Hervé Le Marec; B Bénichou
Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28.
American journal of human genetics 1998;62(3):627-32.
1998: Edith Fressinaud; Agnès Veyradier; F Truchaud; I Martin; C Boyer-Neumann; Marc Trossaert; Dominique Meyer
Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases.
Blood 1998;91(4):1325-31.
1998: Agnès Veyradier; Edith Fressinaud; D Meyer
Laboratory diagnosis of von Willebrand disease.
International journal of clinical & laboratory research 1998;28(4):201-10.
1997: Dominique Meyer; Edith Fressinaud; Christine Gaucher; Jean-Maurice Lavergne; Lysiane Hilbert; Anne-Sophie Ribba; Sylvie Jorieux; Claudine Mazurier
Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand Disease.
Thrombosis and haemostasis 1997;78(1):451-6.
1996: Jean Amiral; Anne Marfaing-Koka; M Wolf; M C Alessi; B Tardy; C Boyer-Neumann; Anne Marie Vissac; Edith Fressinaud; M Poncz; D Meyer
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia.
Blood 1996;88(2):410-6.
1995: C Guérois; Yves Laurian; Chantal Rothschild; A Parquet-Gernez; A M Duclos; Claude Négrier; M Vicariot; Béatrice Fimbel; Edith Fressinaud; M Fiks-Sigaud
Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
Thrombosis and haemostasis 1995;73(2):215-8.
1995: Jean Amiral; F Bridey; M Wolf; C Boyer-Neumann; Edith Fressinaud; Anne Marie Vissac; E Peynaud-Debayle; M Dreyfus; D Meyer
Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Thrombosis and haemostasis 1995;73(1):21-8.
1994: Edith Fressinaud; A B Federici; G Castaman; Chantal Rothschild; F Rodeghiero; H R Baumgartner; P M Mannucci; D Meyer
The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease.
British journal of haematology 1994;86(2):327-32.
1993: M Vicariot; Edith Fressinaud; M Fiks; J Fonlupt; A M Berthier; C Guerois; Béatrice Fimbel
[HIV infection among type A and B hemophiliacs].
Revue française de transfusion et d'hémobiologie : bulletin de la Société nationale de transfusion sanguine 1993;36(5):417-26.
1993: Edith Fressinaud; A B Federici; G Castaman; P M Mannucci; D Meyer
Ex vivo experimental thrombosis in variants of von Willebrand disease.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(10):1260-5.
1993: M Tartary; D Vidaud; Y Piao; J M Costa; B R Bahnak; Edith Fressinaud; B Congard; Yves Laurian; D Meyer; Jean-Maurice Lavergne
Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis.
British journal of haematology 1993;84(4):662-9.
1993: D Vidaud; M Tartary; J M Costa; B R Bahnak; S Gispert-Sanchez; Edith Fressinaud; C Gazengel; D Meyer; Michel Goossens; Jean-Maurice Lavergne
Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
Human genetics 1993;91(3):241-4.
1993: M Fiks-Sigaud; L Bendelac; Armelle Parquet; F Verroust; M F Torchet; A M Berthier; Edith Fressinaud; C Guerois; M F Aillaud; B Boneu
Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A. A French Multicentric Study.
Vox sanguinis 1993;64(4):210-4.
1992: Jean-Pierre Girma; Edith Fressinaud; O Christophe; C Rouault; Bernadette Obert; Y Takahashi; D Meyer
Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
Thrombosis and haemostasis 1992;68(6):707-13.
1992: Jean-Maurice Lavergne; L De Paillette; B R Bahnak; Anne-Sophie Ribba; Edith Fressinaud; D Meyer; G Pietu
Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.
British journal of haematology 1992;82(1):66-72.
1992: Edith Fressinaud; K S Sakariassen; Chantal Rothschild; H R Baumgartner; D Meyer
Shear rate-dependent impairment of thrombus growth on collagen in nonanticoagulated blood from patients with von Willebrand disease and hemophilia A.
Blood 1992;80(4):988-94.
1992: Jean Amiral; F Bridey; M Dreyfus; A M Vissoc; Edith Fressinaud; M Wolf; D Meyer
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.
Thrombosis and haemostasis 1992;68(1):95-6.
1991: D Meyer; Geneviève Piétu; Edith Fressinaud; Jean-Pierre Girma
von Willebrand factor: structure and function.
Mayo Clinic proceedings. Mayo Clinic 1991;66(5):516-23.
1991: Edith Fressinaud; D Meyer
von Willebrand factor and platelet interactions with the vessel wall.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(2):333-40.
1990: Edith Fressinaud; Jean-Pierre Girma; J E Sadler; H R Baumgartner; D Meyer
Synthetic RGDS-containing peptides of von Willebrand factor inhibit platelet adhesion to collagen.
Thrombosis and haemostasis 1990;64(4):589-93.
1989: M Nishino; Jean-Pierre Girma; Chantal Rothschild; Edith Fressinaud; D Meyer
New variant of von Willebrand disease with defective binding to factor VIII.
Blood 1989;74(5):1591-9.
1988: Edith Fressinaud; Dominique Baruch; Jean-Pierre Girma; K S Sakariassen; H R Baumgartner; D Meyer
von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib.
The Journal of laboratory and clinical medicine 1988;112(1):58-67.
1987: Edith Fressinaud; Dominique Baruch; Chantal Rothschild; H R Baumgartner; D Meyer
Platelet von Willebrand factor: evidence for its involvement in platelet adhesion to collagen.
Blood 1987;70(4):1214-7.
1987: G Pietu; Edith Fressinaud; Jean-Pierre Girma; H K Nieuwenhuis; C Rothschild; D Meyer
Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets.
The Journal of laboratory and clinical medicine 1987;109(6):637-46.
1987: K S Sakariassen; Edith Fressinaud; Jean-Pierre Girma; D Meyer; H R Baumgartner
Role of platelet membrane glycoproteins and von Willebrand factor in adhesion of platelets to subendothelium and collagen.
Annals of the New York Academy of Sciences 1987;516():52-65.
1987: D Meyer; Edith Fressinaud; K S Sakariassen; H R Baumgartner; Jean-Pierre Girma
Role of von Willebrand factor in platelet vessel-wall interactions.
Annals of the New York Academy of Sciences 1987;509():118-30.
1986: K S Sakariassen; Edith Fressinaud; Jean-Pierre Girma; H R Baumgartner; D Meyer
Mediation of platelet adhesion to fibrillar collagen in flowing blood by a proteolytic fragment of human von Willebrand factor.
Blood 1986;67(5):1515-8.